92 related articles for article (PubMed ID: 19020245)
1. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
Veldman MW; Reading CC; Farrell MA; Mullan BP; Wermers RA; Grant CS; Thompson GB
AJR Am J Roentgenol; 2008 Dec; 191(6):1740-4. PubMed ID: 19020245
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1.
Singh Ospina N; Thompson GB; Lee RA; Reading CC; Young WF
J Clin Endocrinol Metab; 2015 Jan; 100(1):E87-90. PubMed ID: 25337928
[TBL] [Abstract][Full Text] [Related]
3. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Hubbard JG; Sebag F; Maweja S; Henry JF
Arch Surg; 2006 Mar; 141(3):235-9. PubMed ID: 16549687
[TBL] [Abstract][Full Text] [Related]
4. Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
Tonelli F; Marcucci T; Fratini G; Tommasi MS; Falchetti A; Brandi ML
Ann Surg; 2007 Dec; 246(6):1075-82. PubMed ID: 18043113
[TBL] [Abstract][Full Text] [Related]
5. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?
Dotzenrath C; Cupisti K; Goretzki PE; Yang Q; Simon D; Ohmann C; Röher HD
Eur J Surg; 2001 Mar; 167(3):173-8. PubMed ID: 11316400
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1.
Arnalsteen LC; Alesina PF; Quiereux JL; Farrel SG; Patton FN; Carnaille BM; Cardot-Bauters CM; Wemeau JL; Proye CA
Surgery; 2002 Dec; 132(6):1119-24; discussion 1124-5. PubMed ID: 12490864
[TBL] [Abstract][Full Text] [Related]
7. Hyperparathyroidism and multiple endocrine neoplasia.
Malone JP; Srivastava A; Khardori R
Otolaryngol Clin North Am; 2004 Aug; 37(4):715-36, viii. PubMed ID: 15262511
[TBL] [Abstract][Full Text] [Related]
8. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.
Pieterman CR; van Hulsteijn LT; den Heijer M; van der Luijt RB; Bonenkamp JJ; Hermus AR; Borel Rinkes IH; Vriens MR; Valk GD;
Ann Surg; 2012 Jun; 255(6):1171-8. PubMed ID: 22470073
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.
Katai M; Sakurai A; Ikeo Y; Hashizume K
Horm Metab Res; 2001 Aug; 33(8):499-503. PubMed ID: 11544565
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
Melck AL; Carty SE; Seethala RR; Armstrong MJ; Stang MT; Ogilvie JB; Yip L
Surgery; 2010 Oct; 148(4):867-73; discussion 873-5. PubMed ID: 20800255
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism.
Solbiati L; Giangrande A; De Pra L; Bellotti E; Cantù P; Ravetto C
Radiology; 1985 Jun; 155(3):607-10. PubMed ID: 3889999
[TBL] [Abstract][Full Text] [Related]
12. Non-surgical therapy of primary hyperparathyroidism.
Howell P; Kariampuzha S; Kipgen W; Baker MZ; Tytle TL; Williams GR; Scofield RH
J Okla State Med Assoc; 2001 Dec; 94(12):561-5. PubMed ID: 11775385
[TBL] [Abstract][Full Text] [Related]
13. Nonsurgical treatment of primary hyperparathyroidism with sonographically guided percutaneous injection of ethanol: results in a selected series of patients.
Karstrup S; Holm HH; Glenthøj A; Hegedüs L
AJR Am J Roentgenol; 1990 May; 154(5):1087-90. PubMed ID: 2108547
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transcatheter ablation of parathyroid gland tumors by alcohol injection and contrast media infusion].
Günther R; Beyer J; Hesch H; Reinwein D
Rofo; 1984 Jan; 140(1):27-30. PubMed ID: 6420260
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates.
Lee CH; Tseng LM; Chen JY; Hsiao HY; Yang AH
Ann Surg Oncol; 2006 Jan; 13(1):103-9. PubMed ID: 16378158
[TBL] [Abstract][Full Text] [Related]
17. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.
Kivlen MH; Bartlett DL; Libutti SK; Skarulis MC; Marx SJ; Simonds WF; Weinstein LS; Jensen RT; McCart JA; Naik AM; Kranda KC; Brennan MF; Norton JA; Fraker DL; Alexander HR
Surgery; 2001 Dec; 130(6):991-8. PubMed ID: 11742328
[TBL] [Abstract][Full Text] [Related]
18. Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Waldmann J; López CL; Langer P; Rothmund M; Bartsch DK
Br J Surg; 2010 Oct; 97(10):1528-34. PubMed ID: 20629112
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid surgery in familial hyperparathyroid disorders.
Carling T; Udelsman R
J Intern Med; 2005 Jan; 257(1):27-37. PubMed ID: 15606374
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for dogs with primary hyperparathyroidism following treatment with percutaneous ultrasound-guided ethanol ablation of presumed functional parathyroid nodules: 27 cases (2008-2011).
Guttin T; Knox VW; Diroff JS
J Am Vet Med Assoc; 2015 Oct; 247(7):771-7. PubMed ID: 26383753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
